Childhood asthma outcomes during the COVID-19 pandemic: Findings from the PeARL multi-national cohort.
Papadopoulos G NikolaosAlexander G MathioudakisAdnan CustovicAntoine DeschildreWanda PhipatanakulGary Wing Kin WongParaskevi XepapadakiRola Abou-TaamIoana AgacheJose A Castro-RodriguezZhimin ChenPierrick CrosJean-Christophe DubusZeinab Awad El-SayedRasha El OwaidyWojciech FeleszkoVincenzo FierroAlessandro Giovanni FiocchiLuis Garcia-MarcosAnne GohElham M HossnyYunuen R Huerta VillalobosTuomas JarttiPascal Le RouxJulia LevinaAida Inés López GarcíaÁngel Mazón RamosMario Morais-AlmeidaClare MurrayKarthik NagarajuMajor K NagarajuElsy Maureen Navarrete RodriguezLeyla Namazova-BaranovaAntonio Nieto GarciaCesar Fireth Pozo BeltránThanaporn RatchataswanDaniela Rivero YeverinoEréndira Rodríguez ZagalCyril E SchweitzerMarleena TulkkiKatarzyna WasilczukDan Xunull nullPublished in: Allergy (2021)
Childhood asthma outcomes, including control, were improved during the first wave of the COVID-19 pandemic, probably because of reduced exposure to asthma triggers and increased treatment adherence. The decreased frequency of acute episodes does not support the notion that childhood asthma may be a risk factor for COVID-19. Furthermore, the potential for improving childhood asthma outcomes through environmental control becomes apparent.
Keyphrases
- chronic obstructive pulmonary disease
- lung function
- allergic rhinitis
- early life
- sars cov
- coronavirus disease
- childhood cancer
- type diabetes
- air pollution
- quality improvement
- computed tomography
- magnetic resonance
- liver failure
- metabolic syndrome
- glycemic control
- intensive care unit
- skeletal muscle
- risk assessment
- young adults
- insulin resistance
- aortic dissection
- acute respiratory distress syndrome